Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Provided By GlobeNewswire

Last update: May 15, 2024

Announced positive data from Cohort 1 of the Phase 1b clinical trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) patients with positive trends observed in seven of the eight biomarkers evaluated